These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1364626)

  • 1. [Enterosorption in the treatment of ulcerative colitis patients].
    Bereza NM; Selezneva SI; Mosalova NM; Boĭko TI; Cherniakova VI; Shevtsova ZI; Kudriavtseva VE
    Lik Sprava; 1992 Jan; (1):97-100. PubMed ID: 1364626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Ozone therapy combined with sulfasalazine delivered via a colon therapy system for treatment of ulcerative colitis].
    Geng Y; Wang W; Ma Q; Peng LQ; Liang ZH
    Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2683-5. PubMed ID: 21177179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Levamisole and splenin in combined therapy of patients with bronchiectasis].
    Sokhin AA; Monogarova NE; Zeligman VS; Chernykh SN; Radugina GS
    Klin Med (Mosk); 1989 Sep; 67(9):38-41. PubMed ID: 2586038
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoactive drugs in the combined modality therapy of patients with hypothyroidism].
    Epishin AV; Grytsiv VE; Venger EP
    Ter Arkh; 1991; 63(2):88-92. PubMed ID: 2048033
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characteristics of the disorders of the T chain of the immune system in nonspecific ulcerative colitis and their significance in choosing effective therapy].
    Shakhnazarov AA
    Ter Arkh; 1984; 56(2):106-8. PubMed ID: 6608803
    [No Abstract]   [Full Text] [Related]  

  • 6. Chloroquine for mild to moderately active ulcerative colitis: comparison with sulfasalazine.
    Goenka MK; Kochhar R; Tandia B; Mehta SK
    Am J Gastroenterol; 1996 May; 91(5):917-21. PubMed ID: 8633581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Differentiated immunocorrective therapy in nonspecific ulcerative colitis].
    Tkach SM; Bychkova NG; Fomina AA; Perederiĭ VG
    Lik Sprava; 1992 Apr; (4):34-6. PubMed ID: 1441366
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The course and prognosis of ulcerative colitis].
    Dirks E; Goebell H; Eigler FW
    Med Klin (Munich); 1989 Apr; 84(4):208-15. PubMed ID: 2566899
    [No Abstract]   [Full Text] [Related]  

  • 9. [Immunologic aspects of ulcerative colitis].
    Herrerias JM; Pérez Ruilópez MA; Pellicer FJ; Olivan J; Sanchez Cousteau JA; Garrido M
    Rev Esp Enferm Apar Dig; 1977 May; 50(4):409-18. PubMed ID: 887840
    [No Abstract]   [Full Text] [Related]  

  • 10. [The immunocorrective and detoxifying actions of hemosorption, plasmapheresis and enterosorption in pemphigus].
    Grebennikov VA; Beliaevskiĭ AD; Kaminskiĭ MIu; Kuzina ZA; Litvinenko TA
    Vestn Dermatol Venerol; 1990; (5):33-8. PubMed ID: 2402939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conservative treatment of ulcerative colitis: late results.
    Nicolaidis C; Kalliterakis E; Kralios N; Antoniou C
    Proc R Soc Med; 1969 Mar; 62(3):262. PubMed ID: 4388780
    [No Abstract]   [Full Text] [Related]  

  • 12. On the efficacy of ready-made-up commercially available salicylazosulphapyridine enemas in the treatment of proctitis, proctosigmoiditis and ulcerative colitis involving rectum, sigmoid and descending colon.
    Frühmorgen P; Demling L
    Hepatogastroenterology; 1980 Dec; 27(6):473-6. PubMed ID: 6110627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Enterosorption in ulcerative lesions of the gastrointestinal tract with concomitant intestinal dysbacteriosis].
    Krylov AA; Beliakov NA; Sapego AV; Stolov SV
    Ter Arkh; 1996; 68(2):24-7. PubMed ID: 8771651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of splenin for the purpose of immunocorrection in patients with seroresistance following syphilis treatment].
    Bakhmet'eva TM; Lonshakov IuI; Petrova IV
    Vestn Dermatol Venerol; 1988; (10):38-42. PubMed ID: 3223051
    [No Abstract]   [Full Text] [Related]  

  • 15. [Crohn disease and ulcerative colitis].
    Fellhauer M
    Med Monatsschr Pharm; 1990 Sep; 13(9):283-5. PubMed ID: 1978229
    [No Abstract]   [Full Text] [Related]  

  • 16. [Therapy of ulcerative colitis].
    Coltorti M
    Clin Ter; 1974; 70(2):38-73. PubMed ID: 4153248
    [No Abstract]   [Full Text] [Related]  

  • 17. [Taktivin treatment of immunologic disorders in patients with nonspecific ulcerative colitis].
    Shafer NP
    Klin Med (Mosk); 1993; 71(3):45-7. PubMed ID: 8015217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoresponsiveness in ulcerative colitis and Crohn's disease--effect of colectomy and suppression of disease activity.
    Lyanga J; Davis P; Thomson AB
    West J Med; 1988 Apr; 148(4):421-5. PubMed ID: 3388844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience in the treatment of nonspecific ulcerative colitis].
    Karnaukhov VK
    Sov Med; 1973 May; 36(5):93-7. PubMed ID: 4148970
    [No Abstract]   [Full Text] [Related]  

  • 20. [Acquired protein C deficiency in ulcerative colitis. The cause of thromboembolic complications].
    Korsten S; Reis HE
    Dtsch Med Wochenschr; 1992 Mar; 117(11):419-24. PubMed ID: 1347501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.